PERKINS CAPITAL MANAGEMENT INC - Q1 2023 holdings

$106 Thousand is the total value of PERKINS CAPITAL MANAGEMENT INC's 97 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 22.7% .

 Value Shares↓ Weighting
NTRA BuyNATERA INC$3,481
+40.0%
62,700
+1.3%
3.28%
+25.0%
AXGN BuyAXOGEN INC$2,925
-4.5%
309,490
+0.8%
2.76%
-14.7%
OOMA BuyOOMA INC$1,831
-7.5%
146,400
+0.7%
1.73%
-17.4%
AKTS BuyAKOUSTIS TECHNOLOGIES INC$1,692
+180.1%
549,250
+156.2%
1.60%
+150.0%
OPRX BuyOPTIMIZERX CORP$1,490
-12.9%
101,863
+0.1%
1.40%
-22.2%
TCMD BuyTACTILE SYS TECHNOLOGY INC$1,383
+273.8%
84,234
+161.3%
1.30%
+233.5%
BuyMDXHEALTH SAsponsored adr$1,324
+136.0%
408,725
+382.0%
1.25%
+110.8%
FBIO BuyFORTRESS BIOTECH INC$1,164
+116.0%
1,419,013
+72.5%
1.10%
+93.0%
FPAY BuyFLEXSHOPPER INC$1,102
-7.0%
1,296,960
+1.2%
1.04%
-16.9%
EMKR NewEMCORE CORP$961836,000
+100.0%
0.91%
EGHT Buy8X8 INC NEW$882
-2.1%
211,500
+1.4%
0.83%
-12.5%
BuyBIOLASE INC$766
+2453.3%
2,723,481
+5795.5%
0.72%
+2156.2%
APYX BuyAPYX MEDICAL CORPORATION$647
+670.2%
224,800
+527.9%
0.61%
+585.4%
XGN BuyEXAGEN INC$632
+4.3%
259,905
+3.0%
0.60%
-6.9%
BuyBACKBLAZE INC$522
+4.6%
103,335
+27.4%
0.49%
-6.6%
AZYO BuyAZIYO BIOLOGICS INC$416
-62.2%
275,329
+6.3%
0.39%
-66.3%
USB BuyUS BANCORP DEL$349
-7.9%
9,684
+11.5%
0.33%
-17.8%
SHOP NewSHOPIFY INCcl a$2615,450
+100.0%
0.25%
MIRO NewMIROMATRIX MED INC$254151,320
+100.0%
0.24%
LPTH NewLIGHTPATH TECHNOLOGIES INC$192136,300
+100.0%
0.18%
NewG MED HLDGS LTD$182200,000
+100.0%
0.17%
VRAY BuyVIEWRAY INC$174
-22.3%
50,200
+0.6%
0.16%
-30.5%
ARAY BuyACCURAY INC$159
+109.2%
53,500
+46.6%
0.15%
+87.5%
IRIX BuyIRIDEX CORP$91
+4.6%
44,950
+3.5%
0.09%
-6.5%
IMGN BuyIMMUNOGEN INC$83
+33.9%
21,500
+72.0%
0.08%
+20.0%
AMRN BuyAMARIN CORP PLCspons adr new$43
+38.7%
28,500
+11.8%
0.04%
+24.2%
NBSE BuyNEUBASE THERAPEUTICS INC$25
+31.6%
132,500
+33.8%
0.02%
+20.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-09
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NEOGENOMICS INC41Q3 20237.8%
LILY ELI & CO41Q3 20236.9%
PFIZER INC41Q3 20232.9%
ATTUNITY LTD41Q3 20233.6%
EXPEDITORS INTL WASH INC41Q3 20232.3%
CVS HEALTH CORP41Q3 20231.6%
DONALDSON INC41Q3 20231.3%
VERIZON COMMUNICATIONS INC41Q3 20231.0%
US BANCORP DEL41Q3 20230.8%
BAXTER INTL INC40Q3 202314.1%

View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.

Latest significant ownerships (13-D/G)
PERKINS CAPITAL MANAGEMENT INC Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
BIOLASE, INCMay 15, 2023689,1962.1%
FlexShopper, Inc.February 09, 20231,281,4605.9%
Avinger IncFebruary 14, 2020891,7615.2%
Black Ridge Oil & Gas, Inc.February 15, 201930,021,0326.3%
CANCER GENETICS, INCFebruary 15, 20191,135,2504.0%
TearLab CorpFebruary 15, 20191,666,29413.1%
Xtant Medical Holdings, Inc.February 15, 2019684,4083.6%
TearLab CorpJanuary 26, 20184,300,65540.1%
BIO KEY INTERNATIONAL INCFebruary 09, 2017274,9004.4%
EnteroMedics IncFebruary 09, 20171,4550.0%

View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-01-22
13F-HR2023-11-02
13F-HR2023-07-21
SC 13G/A2023-05-15
13F-HR2023-05-09
SC 13G/A2023-02-09
SC 13G2023-02-09
13F-HR2023-01-26
13F-HR2022-10-24
13F-HR2022-07-29

View PERKINS CAPITAL MANAGEMENT INC's complete filings history.

Compare quarters

Export PERKINS CAPITAL MANAGEMENT INC's holdings